Reaching a Rare Disease Community Eager for Treatment Options

19
Reaching a Rare Disease Community Eager for Treatment Options Brian Loew CEO Inspire

description

At the Drug Information Association 2013 conference, Inspire CEO Brian Loew discussed how patients are caregivers affected by rare diseases are organizing in online support communities to share clinical and practical information, and to support one another. Loew focused his presentation on the Inspire/Tuberous Sclerosis Alliance Support Community.

Transcript of Reaching a Rare Disease Community Eager for Treatment Options

Page 1: Reaching a Rare Disease Community Eager for Treatment Options

Reaching a Rare Disease Community Eager for Treatment Options

Brian LoewCEO

Inspire

Page 2: Reaching a Rare Disease Community Eager for Treatment Options

[email protected]@brianloew

Disclaimer

• The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug Information Association, Inc. (“DIA”), its directors, officers, employees, volunteers, members, chapters, councils, Communities (formerly known as SIACs) or affiliates, or any organization with which the presenter is employed or affiliated.

• These PowerPoint slides are the intellectual property of the individual presenter and are protected under the copyright laws of the United States of America and other countries. Used by permission. All rights reserved. Drug Information Association, Drug Information Association Inc., DIA and DIA logo are registered trademarks. All other trademarks are the property of their respective owners.

2

Page 3: Reaching a Rare Disease Community Eager for Treatment Options

[email protected]@brianloew

Our goals for today

• Identify new opportunities to engage with rare disease patient communities.

• Recognize rare disease online patient support communities of highest potential value to your organization.

• Understand how rare disease patients interact online, and the dynamic of the peer-to-peer interactions.

3

Page 4: Reaching a Rare Disease Community Eager for Treatment Options

[email protected]@brianloew 4

Partners in rare disease: 70,000 patients

Page 8: Reaching a Rare Disease Community Eager for Treatment Options

[email protected]@brianloew 8

Benefits of community for patients, especially those with rare diseases

Helps small, geographically-dispersed patients to connect with one another.

A place to share experiences and knowledge, and to help themselves by helping others.

A source of emotional and information support.

Some relationships move from online to in-person.

A way to initiate and promote research.

Page 9: Reaching a Rare Disease Community Eager for Treatment Options

[email protected]@brianloew

About Tuberous Sclerosis Complex (TSC)

9

TSC is a devastating and rare genetic disorder that causes tumors to form in vital organs, primarily the brain, eyes, heart, kidneys, skin and lungs.

Currently there is no cure.

Page 10: Reaching a Rare Disease Community Eager for Treatment Options

[email protected]@brianloew

About Tuberous Sclerosis Alliance

10

• Based in Silver Spring, MD• Founded in 1974 • Dedicated to finding a cure for tuberous sclerosis

complex (TSC), while improving the lives of those affected by TSC

• Develops programs, support services and resource information, stimulating and sponsoring research, and creates public and professional programs designed to increase awareness of TSC

Page 11: Reaching a Rare Disease Community Eager for Treatment Options

[email protected]@brianloew

About the Inspire TSA Support Community

• 1,800 members worldwide• From all U.S. states, and from 70 countries• 6,000 posts per year• Many posts focus on finding treatment options

11

Page 15: Reaching a Rare Disease Community Eager for Treatment Options

[email protected]@brianloew

Search

15

Statistically-improbable phrases

Page 16: Reaching a Rare Disease Community Eager for Treatment Options

[email protected]@brianloew 16

Search

Statistically-improbable phrases

Page 19: Reaching a Rare Disease Community Eager for Treatment Options

[email protected]@brianloew

19

Value is created by patients -- not (only) through ‘traditional’ channels.

Many patients want to contribute to research, but patients need better pathways to access researchers.

Technology matters a great deal.

Technology doesn’t matter at all.

In conclusion...